Bruce D. Hammock

72.5k total citations · 3 hit papers
1.4k papers, 57.6k citations indexed

About

Bruce D. Hammock is a scholar working on Biochemistry, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Bruce D. Hammock has authored 1.4k papers receiving a total of 57.6k indexed citations (citations by other indexed papers that have themselves been cited), including 661 papers in Biochemistry, 464 papers in Molecular Biology and 280 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Bruce D. Hammock's work include Eicosanoids and Hypertension Pharmacology (647 papers), Hormonal Regulation and Hypertension (227 papers) and Alcohol Consumption and Health Effects (180 papers). Bruce D. Hammock is often cited by papers focused on Eicosanoids and Hypertension Pharmacology (647 papers), Hormonal Regulation and Hypertension (227 papers) and Alcohol Consumption and Health Effects (180 papers). Bruce D. Hammock collaborates with scholars based in United States, China and Czechia. Bruce D. Hammock's co-authors include Christophe Morisseau, Shirley J. Gee, John W. Newman, Pavel A. Aronov, Jun Yang, Katja Dettmer, Sung Hee Hwang, John D. Imig, Bora İnceoğlu and Thomas C. Sparks and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Bruce D. Hammock

1.4k papers receiving 56.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mass spectrometry‐based metabolomics

2006 1.6k citations Bruce D. Hammock et al. profile →
Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases

2009 507 citations Bruce D. Hammock et al. profile →
Impact of Soluble Epoxide Hydrolase and Epoxyeicosanoids on Human Health

2012 437 citations Christophe Morisseau, Bruce D. Hammock profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bruce D. Hammock United States	109	24.0k	18.9k	11.3k	7.8k	6.0k	1.4k	57.6k
Helmut Sies Germany	132	8.4k 0.3×	30.1k 1.6×	2.7k 0.2×	4.0k 0.5×	3.1k 0.5×	657	81.4k
Barry Halliwell United Kingdom	176	9.5k 0.4×	45.3k 2.4×	5.0k 0.4×	7.4k 1.0×	5.9k 1.0×	736	138.6k
Marjorie B. Lees United States	39	7.4k 0.3×	23.2k 1.2×	5.3k 0.5×	3.0k 0.4×	1.5k 0.2×	110	65.3k
Frank J. Gonzalez United States	171	10.3k 0.4×	56.6k 3.0×	10.7k 0.9×	5.4k 0.7×	31.3k 5.2×	1.3k	119.2k
Ronald M. Evans United States	187	5.1k 0.2×	96.0k 5.1×	19.8k 1.7×	5.0k 0.6×	5.6k 0.9×	629	148.1k
F. Peter Guengerich United States	127	6.4k 0.3×	27.2k 1.4×	5.0k 0.4×	2.0k 0.3×	37.6k 6.3×	941	68.3k
Irwin Fridovich United States	116	4.1k 0.2×	33.8k 1.8×	2.3k 0.2×	3.5k 0.4×	3.5k 0.6×	420	88.8k
Masayuki Yamamoto Japan	169	5.8k 0.2×	85.7k 4.5×	2.5k 0.2×	4.4k 0.6×	3.5k 0.6×	1.4k	119.9k
Jordi Folch United States	14	7.2k 0.3×	21.3k 1.1×	5.2k 0.5×	2.2k 0.3×	1.4k 0.2×	23	60.8k
Salvador Moncada United Kingdom	161	22.9k 1.0×	26.7k 1.4×	7.3k 0.6×	8.3k 1.1×	2.7k 0.4×	621	123.8k

Countries citing papers authored by Bruce D. Hammock

Since Specialization

Citations

This map shows the geographic impact of Bruce D. Hammock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce D. Hammock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce D. Hammock more than expected).

Fields of papers citing papers by Bruce D. Hammock

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruce D. Hammock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce D. Hammock. The network helps show where Bruce D. Hammock may publish in the future.

Co-authorship network of co-authors of Bruce D. Hammock

This figure shows the co-authorship network connecting the top 25 collaborators of Bruce D. Hammock. A scholar is included among the top collaborators of Bruce D. Hammock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruce D. Hammock. Bruce D. Hammock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xiao, Xiaoyue, Zhenzhen Chen, Jiawei Chen, et al.. (2025). Comparative analysis of immunization strategies for broad-specificity antibody preparation and immunoassay development for sulfonamides detection in chicken and pork samples. Food Bioscience. 67. 106350–106350. 3 indexed citations

Hammock, Bruce D., Sung Hee Hwang, Julian P. Whitelegge, et al.. (2025). Inhibitors of soluble epoxide hydrolase and cGAS/STING repair defects in amyloid-β clearance underlying vascular complications of Alzheimer's disease. Journal of Alzheimer s Disease. 104(1). 150–157. 3 indexed citations

Liu, Man, Qiyi He, El-Sayed A. El-Sheikh, et al.. (2025). Nanobody based immunoassay for detection of aquatic virus: Giant salamander iridovirus. Analytica Chimica Acta. 1350. 343877–343877. 1 indexed citations

Li, Yingxue, Fei Liu, Yifan Liang, et al.. (2024). A new strategy to generate nanobodies for the coumaphos based on the synthesized nanobody libraries. Food Chemistry. 455. 139684–139684. 4 indexed citations

Chen, Zijian, Xiaoqing Huang, Hong Wang, et al.. (2023). A bispecific nanobody with high sensitivity/efficiency for simultaneous determination of carbaryl and its metabolite 1-naphthol in the soil and rice samples. Environmental Pollution. 335. 122265–122265. 14 indexed citations

Бурмистров, В. В., Christophe Morisseau, Tatyana K. Shkineva, et al.. (2023). Adamantyl-ureas with pyrazoles substituted by fluoroalkanes as soluble epoxide hydrolase inhibitors. Journal of Fluorine Chemistry. 266. 110087–110087. 1 indexed citations

McReynolds, Cindy B., Bruce D. Hammock, & Christophe Morisseau. (2023). Regulatory lipid vicinal diols counteract the biological activity of epoxy fatty acids and can act as biomarkers and mechanisms for disease progression. Pharmacology & Therapeutics. 248. 108454–108454. 10 indexed citations

Wang, Yulong, et al.. (2023). An integrated approach to improve the assay performance of quantum dot-based lateral flow immunoassays by using silver deposition. Microchemical Journal. 192. 108932–108932. 7 indexed citations

Wagner, Karen, et al.. (2023). Inhibition of soluble epoxide hydrolase reduces paraquat neurotoxicity in rodents. Environmental Toxicology and Pharmacology. 98. 104070–104070. 2 indexed citations

10.

Yang, Huijuan, Natalia Vasylieva, Jiaxin Wang, et al.. (2023). Precise isolation and structural origin of an ultra-specific nanobody against chemical compound. Journal of Hazardous Materials. 458. 131958–131958. 11 indexed citations

11.

Wang, Yuxin, Christophe Morisseau, Debin Wan, et al.. (2023). PROTAC-Mediated Selective Degradation of Cytosolic Soluble Epoxide Hydrolase Enhances ER Stress Reduction. ACS Chemical Biology. 18(4). 884–896. 3 indexed citations

12.

He, Zhenyun, Xiaolin Huang, Zhichang Sun, et al.. (2023). Illuminating the path: aggregation-induced emission for food contaminants detection. Critical Reviews in Food Science and Nutrition. 65(5). 856–883. 5 indexed citations

13.

Wang, Weicang, Yuxin Wang, Jun Yang, et al.. (2022). Aflatoxin B1 exposure disrupts the intestinal immune function via a soluble epoxide hydrolase-mediated manner. Ecotoxicology and Environmental Safety. 249. 114417–114417. 12 indexed citations

14.

McReynolds, Cindy B., Jun Yang, Alonso Guedes, et al.. (2021). Species Differences in Metabolism of Soluble Epoxide Hydrolase Inhibitor, EC1728, Highlight the Importance of Clinically Relevant Screening Mechanisms in Drug Development. Molecules. 26(16). 5034–5034. 3 indexed citations

15.

Wang, Yulong, Jun‐Li Xu, Yulou Qiu, et al.. (2019). Highly Specific Monoclonal Antibody and Sensitive Quantum Dot Beads-Based Fluorescence Immunochromatographic Test Strip for Tebuconazole Assay in Agricultural Products. Journal of Agricultural and Food Chemistry. 67(32). 9096–9103. 67 indexed citations

16.

Wang, Fuli, Hongyong Zhang, Ai-Hong Ma, et al.. (2017). COX-2/sEH Dual Inhibitor PTUPB Potentiates the Antitumor Efficacy of Cisplatin. Molecular Cancer Therapeutics. 17(2). 474–483. 32 indexed citations

17.

İnceoğlu, Bora, Ahmed Bettaieb, Carlos Antônio Trindade‐da‐Silva, et al.. (2015). Endoplasmic reticulum stress in the peripheral nervous system is a significant driver of neuropathic pain. Proceedings of the National Academy of Sciences. 112(29). 9082–9087. 148 indexed citations

18.

Wang, Lei, Jun Yang, Lei Guo, et al.. (2011). Use of a Soluble Epoxide Hydrolase Inhibitor in Smoke-Induced Chronic Obstructive Pulmonary Disease. American Journal of Respiratory Cell and Molecular Biology. 46(5). 614–622. 42 indexed citations

19.

Liu, Jun‐Yan, See‐Hyoung Park, Christophe Morisseau, et al.. (2009). Sorafenib has soluble epoxide hydrolase inhibitory activity, which contributes to its effect profile in vivo. Molecular Cancer Therapeutics. 8(8). 2193–2203. 68 indexed citations

20.

Xu, Danyan, Ning Li, Yuxia He, et al.. (2006). Prevention and reversal of cardiac hypertrophy by soluble epoxide hydrolase inhibitors. Proceedings of the National Academy of Sciences. 103(49). 18733–18738. 203 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact